Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(20):1497; doi:10.1093/jnci/95.20.1497-b
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content

© 2003 Oxford University Press

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Sentinel Node Biopsy in Breast Cancer

Despite the absence of definitive data from clinical trials on the accuracy and safety of sentinel node biopsy (SNB), the use of SNB has been increasing in clinical practice. To determine the extent and time course of SNB as a replacement for axillary node dissection (AND), Edge et al. (p. 1514) collected clinical data from 3003 cancer patients who were treated at five comprehensive cancer centers. They found that use of SNB alone was common in breast-conserving surgery (BCS), and it was statistically significantly associated with both smaller and larger tumor size and with negative lymph nodes. . . . [Full Text of this Article]

Informed Consent for Mammography

Lack of Evidence for Simian Virus 40 Infection in Humans

Pigmentation, UV Exposure, and Melanoma Risk

Incidence of Childhood Leukemia in Nordic Countries

Effect of Ethnic Neutropenia in Treatment of Breast Cancer